AI assistant
Merck & Co., Inc. — Director's Dealing 2021
Apr 7, 2021
284_dirs_2021-04-07_dba0139f-3d5b-4dc2-884e-d22e22f1991a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-04-01
Reporting Person: LeCointe-Cephas Lisa (SVP Chief Ethics & Com Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1219.346 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $ | 2021-05-04 | Common Stock (694) | Direct | |
| Restricted Stock Unit | $ | 2022-05-03 | Common Stock (876) | Direct | |
| Restricted Stock Unit | $ | 2023-05-01 | Common Stock (1867) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
F5: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.